Close
Help
Login
Staff Login
Register
0
Selected
Invert selection
Deselect all
Deselect all
Add to Cart
Click here to refresh results
Click here to refresh results
Go to Login page
Newsroom Ready: Merck announces Molnupiravir manufacturing in Canada for COVID-19
Newsroom Ready: Merck announces Molnupiravir manufacturing in Canada for COVID-19
Newsroom Ready: Merck announces Molnupiravir manufacturing in Canada for COVID-19
Standard Video
Actions
Overview
Conceptually Similar Documents
CP143754121 | Merck announces Molnupiravir manufacturing in Canada for COVID-19
CP152985172 | Newsroom Ready: Ontario residents react to mask mandates being lifted in most public spaces
CP17178071 | Newsroom Ready: Canada's $850M promise for international COVID-19 fight 'only a beginning'
CP112898221 | Newsroom Ready: Health Canada approves COVID-19 vaccine
CP19569821 | Newsroom Ready: Canada buys options for fifth potential COVID-19 vaccine
CP111820471 | Newsroom Ready: National plans for COVID-19 vaccine distribution in the works: Hajdu
CP18981855 | Newsroom Ready: Health Canada aims to speed COVID-19 vaccine approvals: Tam
CP142522771 | Newsroom Ready: Child COVID-19 vaccinations ramp up in Ontario
CP18576697 | Newsroom Ready: As Russia moves ahead with COVID-19 vaccine, Tam expresses confidence in Health Canada's process
CP142140621 | Newsroom Ready: Plane carrying COVID-19 vaccines for kids touches down in Canada
City
Vaughan
Country
Canada
Add to cart
Select usage
Type of video?
For editorial use only. Video needs to be used in its entirety (i.e. use of select segment(s) not allowed).
Audience Size
Usage description
Add to collection
Add to cart
Newsroom Ready: Merck announces Molnupiravir manufacturing in Canada for COVID-19
Source name:
The Canadian Press
Unique identifier:
CP143756471
Legacy Identifier:
r_COVID-Treatment20211206T1330
Type:
Video
Duration:
2m38s
Dimensions:
1920px × 1080px 195.98 MB
Usage rights:
FOR ONE TIME USE ONLY. NO STORAGE FOR FUTURE USE.
Create Date:
12/6/2021 1:30:00 PM
Display aspect ratio:
16:9
Tags
Coronavirus
COVID-19
Francois-Phillipe Champagne
health
Marwan Akar
Merck
Ontario
oral antiviral medicine
Ryan Turnbull
safety
toronto
treatment
vaccine